Cargando…
Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathways
BACKGROUND: The novel small molecule R118 and the biguanide metformin, a first-line therapy for type 2 diabetes (T2D), both activate the critical cellular energy sensor 5′-AMP-activated protein kinase (AMPK) via modulation of mitochondrial complex I activity. Activation of AMPK results in both acute...
Autores principales: | Jenkins, Yonchu, Sun, Tian-Qiang, Li, Yingwu, Markovtsov, Vadim, Uy, Gerald, Gross, Lisa, Goff, Dane A, Shaw, Simon J, Boralsky, Luke, Singh, Rajinder, Payan, Donald G, Hitoshi, Yasumichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182811/ https://www.ncbi.nlm.nih.gov/pubmed/25252968 http://dx.doi.org/10.1186/1756-0500-7-674 |
Ejemplares similares
-
AMPK Activation through Mitochondrial Regulation Results in Increased Substrate Oxidation and Improved Metabolic Parameters in Models of Diabetes
por: Jenkins, Yonchu, et al.
Publicado: (2013) -
The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice
por: Marcinko, Katarina, et al.
Publicado: (2015) -
The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
por: Agius, Loranne, et al.
Publicado: (2020) -
Preclinical Pharmacokinetics of C118P, a Novel Prodrug of Microtubules Inhibitor and Its Metabolite C118 in Mice, Rats, and Dogs
por: Zhang, Cang, et al.
Publicado: (2018) -
Metabolic regulation by the intestinal metformin-AMPK axis
por: Zhang, Song-Yang, et al.
Publicado: (2022)